Prediction of presurgical metabolic syndrome for gastric cancer‐specific mortality is more evident in smokers: The FIESTA study

• Published in: Cancer medicine (Malden, MA) Vol. 12; no. 3; pp. 3419 - 3432
• Main Authors: Zhang, Xinran, Hu, Dan, Deng, Xiangling, Lin, Jinxiu, Zheng, Xiongwei, Peng, Feng, Meng, Fanqiang, Niu, Wenquan
• Format: Journal Article
• Language: English
• Published: United States John Wiley & Sons, Inc 01.02.2023; John Wiley and Sons Inc; Wiley
• Subjects: Blood pressure; Body mass index; Cancer therapies; Chemotherapy; Cholesterol; Cigarette smoking; Cigarettes; Colorectal cancer; Diabetes; Gastric cancer; Gender; Glucose; Humans; Lymphocytes; Medical prognosis; Metabolic Syndrome; Metastasis; Mortality; Neutrophils; prediction; Predictions; Prospective Studies; Radiation therapy; Risk assessment; Risk Factors; risk score; Skin cancer; Smokers; Smoking; Software; Statistical analysis; Statistical significance; Stomach Neoplasms; Surgery; Survival; Triglycerides; Variables; metabolic syndrome; prediction; gastric cancer; risk score; smoking

Backgrounds We aimed to test whether the prediction of presurgical metabolic syndrome for postsurgical survival outcomes of gastric cancer hinges upon cigarette smoking status. Methods This study is a part of the ongoing Fujian prospective investigation of cancer (FIESTA) study. Patients with gastri...